Global Ischemia Reperfusion Injury Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Publication ID:

GIR092412264

Publication Date:

September 18, 2024

Pages:

119

Publisher:

GIR

Countries:

Global [1]

USD 3,480.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Reperfusion injury or reperfusion insult, sometimes called ischemia-reperfusion injury (IRI) or reoxygenation injury, is the tissue damage caused when blood supply returns to tissue (re- + perfusion) after a period of ischemia or lack of oxygen (anoxia or hypoxia). The absence of oxygen and nutrients from blood during the ischemic period creates a condition in which the restoration of circulation results in inflammation and oxidative damage through the induction of oxidative stress rather than (or along with) restoration of normal function.
The global Ischemia Reperfusion Injury market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.
Global Ischemia Reperfusion Injury key players include Angion Biomedica, Catalyst Biosciences, Ischemix Inc, etc.
North America is the largest market, with a share about 50%, followed by Europe, and Japan, both have a share over 20 percent.
In terms of product, Phase 2 is the largest segment, with a share about 40%. And in terms of application, the largest application is Kidney Injury, followed by Heart Injury, Intestine Injury, etc.
This report is a detailed and comprehensive analysis for global Ischemia Reperfusion Injury market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Ischemia Reperfusion Injury market size and forecasts, in consumption value ($ Million), 2019-2030
Global Ischemia Reperfusion Injury market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global Ischemia Reperfusion Injury market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global Ischemia Reperfusion Injury market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Ischemia Reperfusion Injury
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Ischemia Reperfusion Injury market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Angion Biomedica, Catalyst Biosciences, Ischemix Inc, Opsona Therapeutics, Pharming, TheraSource, Bolder Biotechnology, Corline Biomedical, Mifcortx, Balmes Transplantation, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Ischemia Reperfusion Injury market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segmentation
Ischemia Reperfusion Injury market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Phase 1
Phase 2
Preclinical
Market segment by Application
Heart Injury
Kidney Injury
Intestine Injury
Other Injury
Market segment by players, this report covers
Angion Biomedica
Catalyst Biosciences
Ischemix Inc
Opsona Therapeutics
Pharming
TheraSource
Bolder Biotechnology
Corline Biomedical
Mifcortx
Balmes Transplantation
NovelMed Therapeutics
Hope Pharmaceuticals
Omeros Corp
Prothix
SBI Pharmaceuticals
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Ischemia Reperfusion Injury product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Ischemia Reperfusion Injury, with revenue, gross margin, and global market share of Ischemia Reperfusion Injury from 2019 to 2024.
Chapter 3, the Ischemia Reperfusion Injury competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Ischemia Reperfusion Injury market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Ischemia Reperfusion Injury.
Chapter 13, to describe Ischemia Reperfusion Injury research findings and conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Ischemia Reperfusion Injury by Type
1.3.1 Overview: Global Ischemia Reperfusion Injury Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Ischemia Reperfusion Injury Consumption Value Market Share by Type in 2023
1.3.3 Phase 1
1.3.4 Phase 2
1.3.5 Preclinical
1.4 Global Ischemia Reperfusion Injury Market by Application
1.4.1 Overview: Global Ischemia Reperfusion Injury Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Heart Injury
1.4.3 Kidney Injury
1.4.4 Intestine Injury
1.4.5 Other Injury
1.5 Global Ischemia Reperfusion Injury Market Size & Forecast
1.6 Global Ischemia Reperfusion Injury Market Size and Forecast by Region
1.6.1 Global Ischemia Reperfusion Injury Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Ischemia Reperfusion Injury Market Size by Region, (2019-2030)
1.6.3 North America Ischemia Reperfusion Injury Market Size and Prospect (2019-2030)
1.6.4 Europe Ischemia Reperfusion Injury Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Ischemia Reperfusion Injury Market Size and Prospect (2019-2030)
1.6.6 South America Ischemia Reperfusion Injury Market Size and Prospect (2019-2030)
1.6.7 Middle East & Africa Ischemia Reperfusion Injury Market Size and Prospect (2019-2030)
2 Company Profiles
2.1 Angion Biomedica
2.1.1 Angion Biomedica Details
2.1.2 Angion Biomedica Major Business
2.1.3 Angion Biomedica Ischemia Reperfusion Injury Product and Solutions
2.1.4 Angion Biomedica Ischemia Reperfusion Injury Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Angion Biomedica Recent Developments and Future Plans
2.2 Catalyst Biosciences
2.2.1 Catalyst Biosciences Details
2.2.2 Catalyst Biosciences Major Business
2.2.3 Catalyst Biosciences Ischemia Reperfusion Injury Product and Solutions
2.2.4 Catalyst Biosciences Ischemia Reperfusion Injury Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Catalyst Biosciences Recent Developments and Future Plans
2.3 Ischemix Inc
2.3.1 Ischemix Inc Details
2.3.2 Ischemix Inc Major Business
2.3.3 Ischemix Inc Ischemia Reperfusion Injury Product and Solutions
2.3.4 Ischemix Inc Ischemia Reperfusion Injury Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Ischemix Inc Recent Developments and Future Plans
2.4 Opsona Therapeutics
2.4.1 Opsona Therapeutics Details
2.4.2 Opsona Therapeutics Major Business
2.4.3 Opsona Therapeutics Ischemia Reperfusion Injury Product and Solutions
2.4.4 Opsona Therapeutics Ischemia Reperfusion Injury Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Opsona Therapeutics Recent Developments and Future Plans
2.5 Pharming
2.5.1 Pharming Details
2.5.2 Pharming Major Business
2.5.3 Pharming Ischemia Reperfusion Injury Product and Solutions
2.5.4 Pharming Ischemia Reperfusion Injury Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Pharming Recent Developments and Future Plans
2.6 TheraSource
2.6.1 TheraSource Details
2.6.2 TheraSource Major Business
2.6.3 TheraSource Ischemia Reperfusion Injury Product and Solutions
2.6.4 TheraSource Ischemia Reperfusion Injury Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 TheraSource Recent Developments and Future Plans
2.7 Bolder Biotechnology
2.7.1 Bolder Biotechnology Details
2.7.2 Bolder Biotechnology Major Business
2.7.3 Bolder Biotechnology Ischemia Reperfusion Injury Product and Solutions
2.7.4 Bolder Biotechnology Ischemia Reperfusion Injury Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Bolder Biotechnology Recent Developments and Future Plans
2.8 Corline Biomedical
2.8.1 Corline Biomedical Details
2.8.2 Corline Biomedical Major Business
2.8.3 Corline Biomedical Ischemia Reperfusion Injury Product and Solutions
2.8.4 Corline Biomedical Ischemia Reperfusion Injury Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Corline Biomedical Recent Developments and Future Plans
2.9 Mifcortx
2.9.1 Mifcortx Details
2.9.2 Mifcortx Major Business
2.9.3 Mifcortx Ischemia Reperfusion Injury Product and Solutions
2.9.4 Mifcortx Ischemia Reperfusion Injury Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Mifcortx Recent Developments and Future Plans
2.10 Balmes Transplantation
2.10.1 Balmes Transplantation Details
2.10.2 Balmes Transplantation Major Business
2.10.3 Balmes Transplantation Ischemia Reperfusion Injury Product and Solutions
2.10.4 Balmes Transplantation Ischemia Reperfusion Injury Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Balmes Transplantation Recent Developments and Future Plans
2.11 NovelMed Therapeutics
2.11.1 NovelMed Therapeutics Details
2.11.2 NovelMed Therapeutics Major Business
2.11.3 NovelMed Therapeutics Ischemia Reperfusion Injury Product and Solutions
2.11.4 NovelMed Therapeutics Ischemia Reperfusion Injury Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 NovelMed Therapeutics Recent Developments and Future Plans
2.12 Hope Pharmaceuticals
2.12.1 Hope Pharmaceuticals Details
2.12.2 Hope Pharmaceuticals Major Business
2.12.3 Hope Pharmaceuticals Ischemia Reperfusion Injury Product and Solutions
2.12.4 Hope Pharmaceuticals Ischemia Reperfusion Injury Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Hope Pharmaceuticals Recent Developments and Future Plans
2.13 Omeros Corp
2.13.1 Omeros Corp Details
2.13.2 Omeros Corp Major Business
2.13.3 Omeros Corp Ischemia Reperfusion Injury Product and Solutions
2.13.4 Omeros Corp Ischemia Reperfusion Injury Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Omeros Corp Recent Developments and Future Plans
2.14 Prothix
2.14.1 Prothix Details
2.14.2 Prothix Major Business
2.14.3 Prothix Ischemia Reperfusion Injury Product and Solutions
2.14.4 Prothix Ischemia Reperfusion Injury Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Prothix Recent Developments and Future Plans
2.15 SBI Pharmaceuticals
2.15.1 SBI Pharmaceuticals Details
2.15.2 SBI Pharmaceuticals Major Business
2.15.3 SBI Pharmaceuticals Ischemia Reperfusion Injury Product and Solutions
2.15.4 SBI Pharmaceuticals Ischemia Reperfusion Injury Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 SBI Pharmaceuticals Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Ischemia Reperfusion Injury Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Ischemia Reperfusion Injury by Company Revenue
3.2.2 Top 3 Ischemia Reperfusion Injury Players Market Share in 2023
3.2.3 Top 6 Ischemia Reperfusion Injury Players Market Share in 2023
3.3 Ischemia Reperfusion Injury Market: Overall Company Footprint Analysis
3.3.1 Ischemia Reperfusion Injury Market: Region Footprint
3.3.2 Ischemia Reperfusion Injury Market: Company Product Type Footprint
3.3.3 Ischemia Reperfusion Injury Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Ischemia Reperfusion Injury Consumption Value and Market Share by Type (2019-2024)
4.2 Global Ischemia Reperfusion Injury Market Forecast by Type (2025-2030)
5 Market Size Segment by Application
5.1 Global Ischemia Reperfusion Injury Consumption Value Market Share by Application (2019-2024)
5.2 Global Ischemia Reperfusion Injury Market Forecast by Application (2025-2030)
6 North America
6.1 North America Ischemia Reperfusion Injury Consumption Value by Type (2019-2030)
6.2 North America Ischemia Reperfusion Injury Market Size by Application (2019-2030)
6.3 North America Ischemia Reperfusion Injury Market Size by Country
6.3.1 North America Ischemia Reperfusion Injury Consumption Value by Country (2019-2030)
6.3.2 United States Ischemia Reperfusion Injury Market Size and Forecast (2019-2030)
6.3.3 Canada Ischemia Reperfusion Injury Market Size and Forecast (2019-2030)
6.3.4 Mexico Ischemia Reperfusion Injury Market Size and Forecast (2019-2030)
7 Europe
7.1 Europe Ischemia Reperfusion Injury Consumption Value by Type (2019-2030)
7.2 Europe Ischemia Reperfusion Injury Consumption Value by Application (2019-2030)
7.3 Europe Ischemia Reperfusion Injury Market Size by Country
7.3.1 Europe Ischemia Reperfusion Injury Consumption Value by Country (2019-2030)
7.3.2 Germany Ischemia Reperfusion Injury Market Size and Forecast (2019-2030)
7.3.3 France Ischemia Reperfusion Injury Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Ischemia Reperfusion Injury Market Size and Forecast (2019-2030)
7.3.5 Russia Ischemia Reperfusion Injury Market Size and Forecast (2019-2030)
7.3.6 Italy Ischemia Reperfusion Injury Market Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Ischemia Reperfusion Injury Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Ischemia Reperfusion Injury Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Ischemia Reperfusion Injury Market Size by Region
8.3.1 Asia-Pacific Ischemia Reperfusion Injury Consumption Value by Region (2019-2030)
8.3.2 China Ischemia Reperfusion Injury Market Size and Forecast (2019-2030)
8.3.3 Japan Ischemia Reperfusion Injury Market Size and Forecast (2019-2030)
8.3.4 South Korea Ischemia Reperfusion Injury Market Size and Forecast (2019-2030)
8.3.5 India Ischemia Reperfusion Injury Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Ischemia Reperfusion Injury Market Size and Forecast (2019-2030)
8.3.7 Australia Ischemia Reperfusion Injury Market Size and Forecast (2019-2030)
9 South America
9.1 South America Ischemia Reperfusion Injury Consumption Value by Type (2019-2030)
9.2 South America Ischemia Reperfusion Injury Consumption Value by Application (2019-2030)
9.3 South America Ischemia Reperfusion Injury Market Size by Country
9.3.1 South America Ischemia Reperfusion Injury Consumption Value by Country (2019-2030)
9.3.2 Brazil Ischemia Reperfusion Injury Market Size and Forecast (2019-2030)
9.3.3 Argentina Ischemia Reperfusion Injury Market Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Ischemia Reperfusion Injury Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Ischemia Reperfusion Injury Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Ischemia Reperfusion Injury Market Size by Country
10.3.1 Middle East & Africa Ischemia Reperfusion Injury Consumption Value by Country (2019-2030)
10.3.2 Turkey Ischemia Reperfusion Injury Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Ischemia Reperfusion Injury Market Size and Forecast (2019-2030)
10.3.4 UAE Ischemia Reperfusion Injury Market Size and Forecast (2019-2030)
11 Market Dynamics
11.1 Ischemia Reperfusion Injury Market Drivers
11.2 Ischemia Reperfusion Injury Market Restraints
11.3 Ischemia Reperfusion Injury Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Ischemia Reperfusion Injury Industry Chain
12.2 Ischemia Reperfusion Injury Upstream Analysis
12.3 Ischemia Reperfusion Injury Midstream Analysis
12.4 Ischemia Reperfusion Injury Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Companies Mentioned:

Angion Biomedica
Catalyst Biosciences
Ischemix Inc
Opsona Therapeutics
Pharming
TheraSource
Bolder Biotechnology
Corline Biomedical
Mifcortx
Balmes Transplantation
NovelMed Therapeutics
Hope Pharmaceuticals
Omeros Corp
Prothix
SBI Pharmaceuticals

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂